HEATHER CUMMINGS: Open Payments
NPI 1902283526 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,547 in 135 payments from 21 companies in 2025. Trend: 2023 $1,595 · 2024 $1,829 · 2025 $3,547
Food & beverage: $3,461Education: $86
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $520 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $491 |
| Janssen Biotech, Inc. | 11 | $377 |
| Ardelyx, Inc. | 11 | $336 |
| QOL Medical, LLC | 13 | $315 |
| Ipsen Biopharmaceuticals, Inc | 6 | $248 |
| Novo Nordisk Inc | 4 | $207 |
| Madrigal Pharmaceuticals | 1 | $140 |
| Regeneron Healthcare Solutions, Inc. | 5 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $122 |
Products named: ENTYVIO, TREMFYA, IBSRELA, Sucraid, IQIRVO, RINVOQ, SKYRIZI, Wegovy.
Industry payments across VA — which companies pay providers there.
